Search results
Moderna's MMA candidate nabs spot in FDA pilot for rare disease drugs
FierceBiotech· 1 day agoModerna’s methylmalonic acidemia candidate, mRNA-3705, will be developed under the FDA’s START pilot...
Moderna Investors Just Got Some Bullish News | The Motley Fool
The Motley Fool· 6 days agoModerna (MRNA 3.70%) jumped into the limelight when it started developing a coronavirus vaccine...
Should You Pick Moderna Stock At $150 After 25% Gains In A Month?
Forbes· 2 days agoThe stock price of Moderna has seen a sharp 27% rise in a month, while its peer – BioNTech – has...
Moderna Seeks FDA Approval For Updated COVID-19 Shot For Upcoming Season
Benzinga· 1 day agoOn Friday, Moderna Inc. MRNA announced that it has submitted an FDA application for review of its...
Study shows new cancer vaccine to treat melanoma has 96% survival rate
UNILAD· 4 days agoA new vaccine treatment for skin cancer melanoma has shown extremely promising results in a new...
Is Moderna Inc (MRNA) Set to Underperform? Analyzing the Factors
Guru Focus· 1 day agoLong-established in the Biotechnology industry, Moderna Inc (MRNA, Financial) has enjoyed a stellar reputation. Notably, its diminished rankings in financial strength, growth ...
Updated Covid-19 Vaccine Targeting JN.1 Recommended By FDA Panel
Forbes· 4 days agoThe Vaccines and Related Biological Products Advisory Committee of the FDA evaluated the...
Moderna Files With FDA for Updated Covid Shot
Market Watch· 1 day agoPublished: June 7, 2024 at 11:15 a.m. ETShareResizeBy Dean SealAbout Dow Jones NewswiresDow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world
What the Options Market Tells Us About Moderna - Moderna (NASDAQ:MRNA)
Benzinga· 1 day agoLoading... Loading... Deep-pocketed investors have adopted a bullish approach towards Moderna MRNA , and it's something market players shouldn't ignore. Our tracking of public ...
Moderna (MRNA) Secures FDA Nod for mRNA-Based RSV Vaccine
Zacks via Yahoo Finance· 5 days agoThe RSV vaccine is Moderna???s (MRNA) second FDA-approved product. Once the vaccine secures the...
